This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Xie, H. Articles by Ko, M.-C. Search for Related Content PubMed PubMed Citation Articles by Xie, H. Articles by Ko, M.-C.

---

ANALGESIA

The Spinal Antinociceptive Effects of Endomorphins in Rats: Behavioral and G Protein Functional Studies

Hong Xie, MD, PhD^*, James H. Woods, PhD^*, John R. Traynor, PhD^*, and Mei-Chuan Ko, PhD^*

From the *Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan; Department of Anesthesiology, General Hospital of Tianjin Medical University, Tianjin, China; and Department of Psychology and Graduate Institute of Life Science, National Cheng Chi University, Taipei, Taiwan.

Address correspondence and reprint requests to Dr. M. C. Ko, Department of Pharmacology, University of Michigan, 1301 MSRB III, Ann Arbor, MI 48109-0632. Address e-mail to mko{at}umich.edu.

Abstract

BACKGROUND: Endomorphin-1 and endomorphin-2 are endogenous peptides that are highly selective for µ-opioid receptors. However, studies of their functional efficacy and selectivity are controversial. In this study, we systematically compared the effects of intrathecal (i.t.) administration of endomorphin-1 and -2 on nociception assays and G protein activation with those of [d-Ala²,N-Me-Phe⁴,Gly⁵-ol]-enkephalin (DAMGO), a highly effective peptidic µ-opioid receptor agonist.

METHODS: Male Sprague-Dawley rats were used. Acute and inflammatory pain models were used to compare the duration and magnitude of antinociception. Agonist-stimulated [³⁵S]GTPS binding was used to observe the functional activity at the level of the receptor-G protein in both spinal cord and thalamic membranes. In addition, antagonists selective for each receptor type were used to verify the functional selectivity of endomorphins in the rat spinal cord.

RESULTS: After i.t. administration, endomorphin-1 and -2 produced less antinociceptive effects than DAMGO in the model of acute pain. Concentration–response curves for DAMGO-, endomorphin-1-, and endomorphin-2-stimulated [³⁵S]GTPS binding revealed that both endomorphin-1 and -2 produced less G protein activation (i.e., approximately 50%–60%) than DAMGO did in the membranes of spinal cord and thalamus. In addition, i.t. endomorphin-induced antinociception was blocked by µ-opioid receptor selective dose of naltrexone (P < 0.05), but not by - and -opioid receptor antagonists, naltrindole and nor-binaltorphimine (P > 0.05).

CONCLUSIONS: Endomorphins are partial agonists for G protein activation at spinal and thalamic µ-opioid receptors. Both in vivo and in vitro measurements together suggest that DAMGO is more effective than endomorphins. Spinal endomorphins’ antinociceptive efficacy may range between 53% and 84% depending on the intensity and modality of the nociceptive stimulus.